[1]华楠,师亚,黄姣玲,等.基于CiteSpace的肌少性肥胖研究现状及热点可视化分析[J].军事护理,2023,40(06):48-52.[doi:10.3969/j.issn.2097-1826.2023.06.012]
　HUA Nan,SHI Ya,HUANG Jiaoling,et al.Status Quo and Hotspots of Sarcopenic Obesity Based on CiteSpace:A Visualization Analysis[J].Nursing Journal Of Chinese People's Laberation Army,2023,40(06):48-52.[doi:10.3969/j.issn.2097-1826.2023.06.012]
点击复制

基于CiteSpace的肌少性肥胖研究现状及热点可视化分析
分享到：

《军事护理》[ISSN:2097-1826/CN:31-3186/R]

卷:
40
期数:
2023年06期
页码:
48-52
栏目:
论著
出版日期:
2023-06-15

文章信息/Info

Title:
Status Quo and Hotspots of Sarcopenic Obesity Based on CiteSpace:A Visualization Analysis
文章编号:
2097-1826(2023)06-0048-05
作者:
华楠1; 师亚2; 3; 黄姣玲1; 王秀华1; 刘丹1; 王小清4
(1.中南大学 湘雅护理学院,湖南 长沙 410013; 2.曼彻斯特大学 生物医学与健康学院,曼彻斯特 M13 9PL; 3.扬州大学 护理学院 公共卫生学院,江苏 扬州 225000; 4.中南大学 湘雅二医院,湖南 长沙 410011)
Author(s):
HUA Nan1; SHI Ya2; HUANG Jiaoling1; WANG Xiuhua1; LIU Dan1; WANG Xiaoqing3
(1.Xiangya Nursing School,Central South University,Changsha 410013,Hunan Province,China; 2.School of Biomedical Sciences and Health,University of Manchester,Manchester 44-161,UK; 3.The Second Xiangya Hospital,Central South University,Changsha 410011,Hunan Province,China)
关键词:
肌少症;  肌少性肥胖;  可视化;  文献计量学;  CiteSpace
Keywords:
sarcopenia;  sarcopenic obesity;  visualization;  bibliometrics;  CiteSpace
分类号:
R473.59; R47-05
DOI:
10.3969/j.issn.2097-1826.2023.06.012
文献标志码:
A
摘要:
目的 了解老年肌少性肥胖的研究现状,探究研究趋势,为有效防控肌少性肥胖提供研究依据。方法 2022年11月,以Web of Science Core Collection为数据来源,利用CiteSpace 5.7.R5对2000-2022年间肌少性肥胖相关研究进行可视化分析,系统梳理研究热点及前沿。结果 共纳入肌少性肥胖相关研究672篇,近10年发文量激增; 国家和机构合作研究普遍,研究热点主要集中于肌少性肥胖的筛查和诊断、发病机制、不良结局和干预方面。结论 肌少性肥胖越来越受到广泛关注,研究数量逐年增加; 且国际合作增强。我国在肌少性肥胖领域研究尚处于初步探索阶段,未来可借鉴国际优秀研究经验深入研究。
Abstract:
Objective To explore the status quo and trend of senile sarcopenic obesity(SO),so as to provide research basis for effective prevention and control of SO.Methods Using Web of Science Core Collection(WOSCC)as the data source,CiteSpace 5.7.R5 was used to visualize and analyze the researches related to SO from 2000 to 2022,and systematically sort out the research hotspots and frontiers.Results A total of 672 articles on SO were included,and the number of articles published in the past 10 years increased dramatically.National and institutional collaborative research was common,and the research hotspots mainly focused on screening and diagnosis of SO,pathogenesis,adverse outcomes and interventions.Conclusions SO has attracted increasing attention,with the research number increasing year by year and international cooperation strengthening.China is still in the preliminary exploration stage in this field.Excellent international research experience can be learned to further the study in this field.

参考文献/References:

[1] BAUMGARTNER R N.Body composition in healthy aging[J].Ann N Y Acad Sci,2000(904):437-448.
[2] SHAO A,CAMPBELL W W,CHEN C Y O,et al.The emerging global phenomenon of sarcopenic obesity:role of functional foods; a conference report[J].J Funct Foods,2017(33):244-250.
[3] SCOTT D,SEIBEL M,CUMMING R,et al.Sarcopenic obesity and its temporal associations with changes in bone mineral density,incident falls,and fractures in older men:the concord health and ageing in men project[J].J Bone Miner Res,2017,32(3): 575-583.
[4] WANNAMETHEE S G,ATKINS J L.Muscle loss and obesity:the health implications of sarcopenia and sarcopenic obesity[J].Proc Nutr Soc,2015,74(4):405-412.
[5] LEE J,HONG Y P,SHIN H J,et al.Associations of sarcopenia and sarcopenic obesity with metabolic syndrome considering both muscle mass and muscle strength[J].J Prev Med Public Health,2016,49(1):35-44.
[6] BATSIS J A,VILLAREAL D T.Sarcopenic obesity in older adults:aetiology,epidemiology and treatment strategies[J].Nat Rev Endocrinol,2018,14(9):513-537.
[7] KOKKELER K J E,VAN DEN BERG K S,COMIJS H C,et al.Sarcopenic obesity predicts nonremission of late-life depression[J].Int J Geriatr Psychiatry,2019,34(8):1226-1234.
[8] 国务院第七次全国人口普查领导小组办公室.第七次全国人口普查[EB/OL].[2021-08-07].http://www.stats.gov.cn/ztjc/zdtjgz/zgrkpc/dqcrkpc/ggl/202105/t20210519_1817698.html.
[9] FLEGAL K M,KRUSZON-MORAN D,CARROLL M D,et al.Trends in obesity among adults in the United States,2005 to 2014[J].JAMA,2016,315(21):2284-2291.
[10]张曼,蔡春凤.基于CiteSpace的护理缺失相关研究热点的可视化分析[J].解放军护理杂志,2021,38(8):46-49.
[11]CHEN L K,WOO J,ASSANTACHAI P,et al.Asian Working group for sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Dir Assoc,2020,21(3):300-307.
[12]ROH E,CHOI K M.Health consequences of sarcopenic obesity:a narrative review[J/OL].[2022-05-30].https://www.frontiersin.org/articles/10.3389/fendo.2020.00332/full.DOI:10.3389/fendo.2020.00332.
[13]KIM T N,PARK M S,RYU J Y,et al.Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study:the Korean sarcopenic obesity study(KSOS)[J/OL].[2022-05-30].https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0115407.DOI:10.1371/journal.pone.0115407.
[14]HONG S H,CHOI K M.Sarcopenic obesity,insulin resistance,and their implications in cardiovascular and metabolic consequences[J/OL].[2022-05-30].https://www.mdpi.com/1422-0067/21/2/494.DOI:10.3390/ijms21020494.
[15]FUKUDA T,BOUCHI R,TAKEUCHI T,et al.Sarcopenic obesity assessed using dual energy X-ray absorptiometry(DXA)can predict cardiovascular disease in patients with type 2 diabetes:a retrospective observational study[J/OL].[2022-05-30].https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0700-5.DOI:10.1186/s12933-018-0700-5.
[16]DONINI L M,BUSETTO L,BISCHOFF S C,et al.Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement[J].Clin Nutr,2022,41(4): 990-1000.
[17]MO Y H,YANG C,SU Y D,et al.Prevalence and diagnostic agreement of sarcopenic obesity with different definitions among Chinese community-dwelling older adults[J/OL].[2022-06-05].https://www.socolar.com/Article/Index?aid=10009194207 6&jid=100000002090.DOI:10.1093/ageing/afab272.
[18]KIM Y J,MOON S,YU J M,et al.Implication of diet and exercise on the management of age-related sarcopenic obesity in Asians[J].Geriatr Gerontol Int,2022,22(9):695-704.
[19]CONLEY K E,ESSELMAN P C,JUBRIAS S A,et al.Ageing,muscle properties and maximal O2 uptake rate in humans[J].J Physiol,2000,526(Pt 1):211-217.
[20]WANG M,TAN Y,SHI Y,et al.Diabetes and sarcopenic obesity:pathogenesis,diagnosis,and treatments[J/OL].[2022-02-10].https://www.frontiersin.org/articles/10.3389/fendo.2020.00568/full.DOI:10.3389/fendo.2020.00568.
[21]PATEL V S,CHAN M E,RUBIN J,et al.Marrow adiposity and hematopoiesis in aging and obesity:exercise as an intervention[J].Curr Osteoporos Rep,2018,16(2):105-115.
[22]MATULEWICZ N,KARCZEWSKA-KUPCZEWSKA M.Insulin resistance and chronic inflammation[J].Postepy Hig Med Dosw,2016(70):1245-1258.
[23]CHOI K M.Sarcopenia and sarcopenic obesity[J].Korean J Intern Med,2016,31(6):1054-1060.
[24]KOLIAKI C,LIATIS S,DALAMAGA M,et al.Sarcopenic obesity:epidemiologic evidence,pathophysiology,and therapeutic perspectives[J].Curr Obes Rep,2019,8(4):458-471.
[25]PÉREZ-CRUZ E,CASTRO-MARTÍNEZ D,GONZÁLEZ-GUZMAN O P.Association between sarcopenic obesity with insulin resistance and metabolic syndrome[J].Med Clin(Barc),2022,159(1):1-5.
[26]SANADA K,CHEN R,WILLCOX B,et al.Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men:the Kuakini Honolulu heart program[J].Nutrition,2018(46): 97-102.
[27]张凤,杜建,冷吉燕.肌肉减少症与恶病质[J].中国老年学杂志,2022,42(4): 999-1006.
[28]BIOLO G,CEDERHOLM T,MUSCARITOLI M.Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases:from sarcopenic obesity to cachexia[J].Clin Nutr,2014,33(5): 737-748.
[29]DEUTZ N E P,BAUER J M,BARAZZONI R,et al.Protein intake and exercise for optimal muscle function with aging:recommendations from the ESPEN Expert Group[J].Clin Nutr,2014,33(6):929-936.
[30]MOYER V A,U.S.Preventive Services Task Force.Vitamin D and calcium supplementation to prevent fractures in adults:U.S. preventive services task force recommendation statement[J].Ann Intern Med,2013,158(9): 691-696.
[31]MUIR S W,MONTERO-ODASSO M.Effect of vitamin D supplementation on muscle strength,gait and balance in older adults:a systematic review and Meta-analysis[J].J Am Geriatr Soc,2011,59(12):2291-2300.

相似文献/References:

[1]闵文珺,陈亚梅,卢群,等.老年肌少症患者运动干预的最佳证据总结[J].军事护理,2022,39(03):75.[doi:10.3969/j.issn.1008-9993.2022.03.018]
　MIN Wenjun,CHEN Yamei,LU Qun,et al.Best Evidence Summary of Exercise Intervention for Elderly Patients with Sarcopenia[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(06):75.[doi:10.3969/j.issn.1008-9993.2022.03.018]
[2]邓菲菲,赵智芳,李建琼,等.社区老年肌少症风险筛查工具与方法的研究进展[J].军事护理,2023,40(05):82.[doi:10.3969/j.issn.2097-1826.2023.05.020]

备注/Memo

备注/Memo:
【 收稿日期 】2022-02-18【 修回日期 】2023-03-22
【 基金项目 】湖南省发展和改革委员会创新研发课题项目(湘发改投资[2021]212号); 湖南省科技厅重点研发项目[2018SK21312]
【 作者简介 】华楠,硕士在读,电话:0731-82651266
【 通信作者 】王秀华,电话:0731-82650291
更新日期/Last Update: 2023-06-15